The first relapse in multiple myeloma: how to pick the next best thing.
Document Type
Article
Publication Title
Hematology. American Society of Hematology. Education Program
Abstract
The choice of treatment for patients with multiple myeloma (MM) at first relapse/progression is based on many factors: (1) treatment-related factors, which include the regimen used during first induction, the quality and duration of first response achieved, toxicities from the first treatment, whether the patient underwent autologous stem cell transplant, and whether the patient was on maintenance at the time of relapse/progression; (2) disease-related factors, including disease presentation and pace of progression; and (3) patient-related factors, including functional age and performance status. The learning objectives are to present the treatment options for patients with MM upon their first relapse and to learn about various strategies for selecting an optimal treatment regimen.
First Page
560
Last Page
568
DOI
10.1182/hematology.2022000356
Publication Date
12-9-2022
Recommended Citation
Devarakonda S, Sharma N, Efebera Y. The first relapse in multiple myeloma: how to pick the next best thing. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):560-568. doi: 10.1182/hematology.2022000356. PMID: 36485087; PMCID: PMC9821240.